Emil raises Rs 150 cr from Somerset Indus Capital
"The investment is through a mix of primary (Rs 120 crore) and secondary (Rs 30 crore) sale," said Tushar Korday director, Emil Pharmaceutical. "The investment outlay may increase in the near future," Korday added, but the company did not disclose the size of the minority stake.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
